This newsletter is a part of our 2023 Stakeholders’ Series. Through this channel you’ll get industry, program, and IHA-wide insights, in a more tailored and timely way.
Don’t miss it: register for Transition to ECDS-only reporting: Breast Cancer Screening
You have less than a week left to register for the Transition to ECDS-only reporting: Breast Cancer Screening webinar, hosted by IHA and presented by NCQA.
As a reminder, the Breast Cancer Screening (BCS) measure will transition to the exclusive use of the Electronic Clinical Data Systems (ECDS) reporting for MY 2023. We encourage you to review last year’s three-part technical training series which provides an introduction to ECDS reporting. Also, AMP participants will need to purchase the BCS-E digital measure package which is included in the MY 2023 AMP Digital Measure Bundle on the NCQA Store Page.
We had a fantastic turnout for our first-ever Health Policy Update webinar in June! Many thanks to our speakers for the timely legislative and policy updates, panel discussion on the new Office of Health Care Affordability, and overview of activities designed to improve provider directories. If you missed the webinar, you can catch the replay here.
In the pipeline:
MY 2022 Preliminary Results Release Webinar
Join us on August 10, 2023, for an overview of the MY 2022 preliminary AMP results. We’ll dive into performance insights, how to review your results using Onpoint’s Performance Reporting Portal (PRP), and what to do if you have questions or appeals. If you aren’t able to attend, the session will be recorded and made available on our website.
Questions and appeals period for MY 2022 preliminary results
The MY 2022 questions and appeals period will begin on August 10 and end on September 1 for FinThrive-generated results and September 8 for Onpoint and PBGH-generated results. This allows provider organizations and health plans to review their MY 2022 preliminary results and check for possible errors. We encourage you to submit questions or appeals early to give IHA and partners enough time to thoroughly investigate your submission. Resources on how to review AMP data and how to submit a question or an appeal will be published on the IHA website in the coming weeks.
As a reminder, AMP MY 2022 results will be released via the Onpoint Performance Reporting Portal (PRP); we will also use the PRP to release refreshed MY 2021 results.
Please prepare for the upcoming questions and appeals period by confirming that all members of your team have access to the PRP prior to the preliminary results release on August 10. Your organization’s admin has the ability to edit, remove, and add new users. View further instructions on how PRP admins can edit contacts on the portal here.
For further questions about PRP account set-up, please contact amp@iha.org.
Important activities and associated dates
August 10: Preliminary MY 2022 results released to participants.
August 10 – September 1: Questions and appeals submission period for FinThrive (formerly TransUnion) pipeline. Please note the shorter timeframe due to the complexities of the FinThrive pipeline.
August 10 – September 8: Questions and appeals submission period for Onpoint and PBGH pipelines.
September 8: If the questions and appeals period results in necessary resubmissions via the FinThrive pipeline, health plans must resubmit FinThrive results to their auditor by September 8. FinThrive must receive auditor-locked resubmissions by September 15.
September 14: If the questions and appeals period results in necessary resubmissions via the Onpoint pipeline, health plans must resubmit to Onpoint by September 14 and files must be in passing status by September 21.
September 15: Last day to finalize any communications and documentation related to questions and appeals.
September 20: Appeals hearing.
September 27: Appeals decisions communicated to participants.
End of October: Final MY 2022 results released to participants.
Never miss an update
Did someone share this email with you? Receive IHA news and program updates in your inbox by signing up for our newsletter.
